×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IBRX – immunitybio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IBRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
10:14 pm
ibrx
ImmunityBio (IBRX) Climbs 7.3% as Firm Nears Development of ‘World Bank of NK Cells' [Yahoo! Finance]
Neutral
Report
ImmunityBio (IBRX) Climbs 7.3% as Firm Nears Development of ‘World Bank of NK Cells' [Yahoo! Finance]
3/13
07:42 pm
ibrx
Is It Too Late To Reassess ImmunityBio (IBRX) After Its 315% Year To Date Surge [Yahoo! Finance]
Low
Report
Is It Too Late To Reassess ImmunityBio (IBRX) After Its 315% Year To Date Surge [Yahoo! Finance]
3/13
03:47 pm
ibrx
IBRX Stock: Anktiva's Approvals and What Comes Next [Yahoo! Finance]
Low
Report
IBRX Stock: Anktiva's Approvals and What Comes Next [Yahoo! Finance]
3/13
07:43 am
ibrx
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors [Yahoo! Finance]
Medium
Report
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors [Yahoo! Finance]
3/13
07:30 am
ibrx
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
Medium
Report
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
3/12
08:03 am
ibrx
ImmunityBio (IBRX) had its "buy" rating reaffirmed by BTIG Research. They now have a $13.00 price target on the stock.
Medium
Report
ImmunityBio (IBRX) had its "buy" rating reaffirmed by BTIG Research. They now have a $13.00 price target on the stock.
3/10
07:25 am
ibrx
Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX) [Yahoo! Finance]
Medium
Report
Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX) [Yahoo! Finance]
3/10
05:42 am
ibrx
FDA Review And Saudi Approval Keep ANKTIVA Central To ImmunityBio Story [Yahoo! Finance]
Medium
Report
FDA Review And Saudi Approval Keep ANKTIVA Central To ImmunityBio Story [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/26
08:12 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 24 Filed by: Simon Barry J.
Medium
Report
Form 4 ImmunityBio, Inc. For: Feb 24 Filed by: Simon Barry J.
2/25
09:52 pm
ibrx
Form SCHEDULE 13D/A ImmunityBio, Inc. Filed by: Cambridge Equities, LP
Low
Report
Form SCHEDULE 13D/A ImmunityBio, Inc. Filed by: Cambridge Equities, LP
2/24
08:06 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 23 Filed by: Selecky Christobel
High
Report
Form 4 ImmunityBio, Inc. For: Feb 23 Filed by: Selecky Christobel
2/24
08:05 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Adcock Richard
High
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Adcock Richard
2/24
08:05 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: LAUER REGAN J
High
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: LAUER REGAN J
2/24
08:05 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Sachs David C.
High
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Sachs David C.
2/24
08:05 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: SOON-SHIONG PATRICK
High
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: SOON-SHIONG PATRICK
2/24
08:04 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 20 Filed by: Simon Barry J.
High
Report
Form 4 ImmunityBio, Inc. For: Feb 20 Filed by: Simon Barry J.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: